Bone Alkaline Phosphatase Peptide (bs-6292P)

Bone Alkaline Phosphatase Peptide

Quantity size:

500ug

Source:

Synthetic Peptide

Form:

lyophilized powde

Purity:

≥95% (Purified by HPLC)

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

Blocking Peptide of The bs-6292R Antibody

Background:

Defects in ALPL are a cause of hypophosphatasia (HOPS) . HOPS is an inherited metabolic bone disease characterized by defective skeletal mineralization. Four hypophosphatasia forms are distinguished, depending on the age of onset: perinatal, infantile, childhood and adult type. The perinatal form is the most severe and is almost always fatal. Patients with only premature loss of deciduous teeth, but with no bone disease are regarded as having odontohypophosphatasia.

Also known as:

tissue-nonspecific isozyme; AKP2; Alkaline phosphatase; Alkaline phosphatase liver/bone/kidney isozyme; Alpl; AP-TNAP; HOPS; Liver/bone/kidney isozyme; PHOA; PPBT_HUMAN; Tissue non specific alkaline phosphatase; Tissue nonspecific ALP; TNAP; TNSALP.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.